Evidence map›Paper›PMID 40864395›Full record

ReviewNeuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater2026

Services to improve outcomes in severe mental disorders.

Merete Nordentoft

Abstract readReview
In one paragraph

Review in Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Merete NordentoftDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Merete.nordentoft@regionh.dk.ORCID http://orcid.org/0000-0003-4895-7023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe mental disorders, particularly schizophrenia and related disorders, remain among the most disabling and costly health conditions worldwide. Despite advances in pharmacological and psychosocial treatments, recovery rates remain low. Early intervention has emerged as a key strategy to improve outcomes. Reducing the duration of untreated psychosis (DUP) and providing specialized early intervention services-such as Denmark's OPUS, the UK's LEO, and the US Recovery After an Initial Schizophrenia Episode (RAISE) trial-have shown significant benefits in symptom reduction, functioning, and cost-effectiveness. Assertive Community Treatment (ACT), Individual Placement and Support (IPS), and Housing First programs further enhance recovery for individuals with complex needs, including comorbid substance use and homelessness. Innovative therapies, such as avatar-based treatment for persistent hallucinations, show promise in treatment-resistant cases. Children of parents with severe mental illness are at elevated risk and offer a unique opportunity for prevention. The Danish High Risk and Resilience Study (VIA 7), which follows high-risk children from age 7 to 19, exemplifies how longitudinal research can identify early modifiable risk factors and inform timely interventions. To improve long-term outcomes, services must be coordinated, person-centered, and recovery-oriented-delivering care that is accessible, humane, and tailored to the individual's stage of illness and life circumstances.

Indexed as

Early Medical InterventionMental DisordersPsychotic DisordersSchizophreniaAdolescentAdultChildCommunity Mental Health ServicesCost-Benefit AnalysisDenmarkHumansIntersectoral CollaborationSchizophrenic PsychologyTreatment OutcomeAssertive community treatmentEarly intervention servicesHomelessnessPsychosisSchizophrenia

Identifiers

PMID40864395
PMCPMC13233947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.